Filter
87
Filtered Results: 87
Text search:
P.
Glaziou
Featured
Recommendations
13
New Publications
11
Language
Document type
No document type
41
Guidelines
27
Studies & Reports
15
Manuals
2
Fact sheets
2
Countries / Regions
Russia
5
Eastern Europe
4
Ukraine
3
Western and Central Europe
3
Brazil
3
Peru
2
Global
2
Asia
2
Latin America and the Carribbean
2
Germany
2
Colombia
1
Timor Leste/ East Timor
1
Kenya
1
Benin
1
Syria
1
Malawi
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
North America
1
Argentina
1
Sudan
1
Yemen
1
Indonesia
1
India
1
Authors & Publishers
Publication Years
Category
COVID-19
11
Guidelines
6
Studies & Reports
6
TB
4
Disease Prevention & Control
3
Reproductive Health
3
Diabetes
2
Monitoring & Evaluation
2
Pediatrics
2
Chagas
2
Policies & Guidelines HIV & TB
2
Paediatrics
1
Bacteriology
1
Sex. & Repr. Rights
1
Infection Control & Prevention (IPC)
1
Public Health
1
Women & Child Health
1
Information, Education and Communication (IEC)
1
Disabilities
1
Capacity Building
1
WASH
1
Respiratory Infections
1
Gynaecology & Obstetrics
1
Health Systems
1
Leprosy
1
HIV & STI
1
Global Health
1
Toolboxes
Prevention & Control
9
Detection & Diagnosis
7
Country specific documents
6
Reports
5
General
5
Medical & Community Masks
5
Policies & Strategies
4
Drug resistant TB
4
Research & Access
4
Adults
3
Children
3
PPE Personel Protective Equipment
3
Advocacy & Communication
3
General
3
ART Drug Resistance
2
General Reports
2
Childhood TB
2
Vaccines & Immunization
2
Ukraine
2
Sustainable Development Goals
2
Russia
2
Clinical Guidelines
2
Infection Control General
2
Diagnostics & Laboratory Guidance
2
Mythbusters/Misinformation
2
HIV &TB
2
Women
2
TB/HIV Coinfection
2
AmR (Region of Americas)
2
TB & Drug Abuse
1
Agriculture & Veterinary
1
Clinical Guidelines
1
Influenza
1
Clinical Guidelines
1
Opoids
1
Drug resistance
1
Eastern Europe
1
TB
1
Prophylaxis
1
Vaccination
1
Climate & Health
1
Treatment Guidelines
1
Infection Prevention & Hygiene
1
Context & Facts, Travel Advice
1
For Health Worker
1
TB/HIV
1
TB/COVID-19
1
Colombia
1
Overview
1
Brazil
1
Nuclear & Chemical Hazards
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Diagnosis
1
Policies and guidelines
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
TB & Prisoners
1
TB/HIV Global
1
Education of students & professionals
1
Tuberculosis
1
HIV service delivery
1
Epidemiology
1
Eastern Europe & Central Asia
1
Neurological disorders, Others
1
SEAR (South-east Asia Region)
1
Treatment & Clinical Management
1
30 October 2017
Monitoring of implementation of collaborative TB/HIV activities and evaluation of impact is critically important. This requires efficient monitoring and evaluation system so as to establish accountability mechanisms between programmes, the population they serve, and donors. The Guide to monitoring a...
BMJ Open Science 2021;5:e100202. doi:10.1136/
bmjos-2021-100202
END TB
Second Meeting of th WHO Global Coordination Mechanism (GCM/NCD) Working Group on the inclusion of NCDs in other programmatic areas.
Accessded December 2017
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Rev Panam Salud Publica. 2020;44:e153.
Este analisis publicada de la Revista Panamericana de Salud Pública determina el comportamiento de los indicadores de incidencia de tuberculosis (TB) y número de muertes por TB en el marco de la meta 3.3 de los Objetivos de Desarrollo Sostenible (ODS) ...
PLoS ONE 9(6): e99880. doi:10.1371/journal.pone.0099880
Published June 17, 2014
International Journal of Drug Policy 24 (2013) e91-98
Цель этого документа – повысить уровень осознания актуальности приоритетных направлений научных исследований по проблеме ТБ/ВИЧ (то есть по тем направлениям, кот...
TB policies in 24 Countries
A survey of prevention, testing and treatment policies and practices
Лечение туберкулеза в 24 странах
Исследование диагностической и клинической практики
Исследование этого года основано на предыдущем отчете. В нем отслеживается утверждение последних стратегий, руководств и методов в пяти сферах: диагностика и иссл...
Автоматизированная технология амплификации нуклеиновых кислот в режиме реального времени для быстрого и одновременного выявления туберкулеза и устойчивости к р...
En la reunión de alto nivel de las Naciones Unidas del 2018 se fijó el objetivo de tratar al menos a 40 millones de personas con tuberculosis (TB) entre el 2018 y el 2022; sin embargo, en el 2021 ese objetivo solo se había cumplido en un 66%. Las pruebas diagnósticas son fundamentales para logra...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
The Global Reference List of 100 Core Health Indicators is a standard set of core indicators prioritized by the global community to provide concise information on the health situation and trends, including responses at national and global levels.
This second (2018) edition builds on the previous ...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
Emerging Infectious Diseases; Vol. 21, No. 11, November 2015
